type here...

CATEGORIES

Innovations

LATEST

1...8910...13Page 9 of 13

TRENDING

EDITORS CHOICE

TaiGen files US IND for its influenza antiviral TG-1000

Medika Life -
TaiGen Biotechnology Company, announced today that it has filed an IND application with the US FDA for its influenza antiviral TG-1000.

Is Innovation an Overused Idea? ViVE is Home to Real-World Health-System Evolution!

Gil Bashe, Medika Life Editor -
Some Conferences Attract the Edgy Ideas of Tomorrow – ViVE 2024 Attracts the Champions of Change Needed Now

CAR T Therapy For Drug Resistant Multiple Myeloma

William Haseltine, PhD -
This is a series on the advances in CAR T, a remarkable immunotherapy treatment dubbed a “living drug.”

“Investigational” Is Payer Code for “Coverage Denied”

Gil Bashe, Medika Life Editor -
Outside the pandemic, “investigational” remains payer code for denying reimbursement. In the case of treatment for chronic conditions, even FDA-approved digital-health and connected devices languish on waitlists for formulary inclusion.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories